pexion
boehringer ingelheim vetmedica gmbh - imepitoin - alte antiepileptice, antiepileptice - câini - pentru reducerea frecvenței convulsiilor generalizate datorate epilepsiei idiopatice la câini pentru utilizare după o evaluare atentă a opțiunilor de tratament alternative.
fenitoina richter 100 mg
gedeon richter romania s.a. - romania - phenytoinum - compr. - 100mg - antiepileptice derivati de hidantoina
fenitoina sodica accord 50 mg/ml
accord healthcare limited - marea britanie - phenytoinum - sol inj./perf. - 50mg/ml - antiepileptice derivati de hidantoina
fenitoina sodica accord 50 mg/ml
accord healthcare limited - marea britanie - phenytoinum - sol inj./perf. - 50mg/ml - antiepileptice derivati de hidantoina
esmya comprimate 5 mg
gedeon richter plc - ulipristalum - comprimate - 5 mg
glivec comprimate filmate 100 mg
novartis pharma ag - imatinibum - comprimate filmate - 100 mg
glivec comprimate filmate 400 mg
novartis pharma ag - imatinibum - comprimate filmate - 400 mg
phenhydan 250 mg/5 ml
desitin arzneimittel gmbh - germania - phenytoinum - sol. inj. - 250mg/5ml - antiepileptice derivati de hidantoina
zydelig
gilead sciences ireland uc - idelalisibul - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
valprocom chrono 300 mg comprimate cu eliberare prelungită
acino ucraina srl - acid sol - comprimate cu eliberare prelungită - 300 mg